Alejandra Carvajal's Net Worth
$1.5 Million
Who is Alejandra Carvajal?
Alejandra Carvajal has an estimated net worth of $1.5 Million. This is based on reported shares across multiple companies, which include Mersana Therapeutics, Inc., Cerulean Pharma Inc., and MOMENTA PHARMACEUTICALS INC.
SEC CIK
Alejandra Carvajal's CIK is 0001645755
Past Insider Trading and Trends
2020 was Alejandra Carvajal's most active year for acquiring shares with 12 total transactions. Alejandra Carvajal's most active month to acquire stocks was the month of December. 2020 was Alejandra Carvajal's most active year for disposing of shares, totalling 23 transactions. Alejandra Carvajal's most active month to dispose stocks was the month of September. 2023 saw Alejandra Carvajal paying a total of $0.00 for 262,833 shares, this is the most they've acquired in one year. In 2020 Alejandra Carvajal cashed out on 409,562 shares for a total of $1,048,260.61, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mersana Therapeutics, Inc. (MRSN) Snapshot price: $3.75
SVP, Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.82% | 7.08K |
$2.71 | -$11,872.51 | 27.4K |
Scheduled
|
Jan 13 - Jan 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 5
| |||
Form 4
| +84.45% | 9.31K |
$3.89 | -$15,342.16 | 20.33K |
Apr 26 - Apr 27
| |||
Form 4
| +18.47% | 1.72K |
$5.74 | -$4,488.68 | 11.02K |
Jan 13 - Jan 17
| |||
Form 4
|
∞
| 9.3K |
$3.69 | -$14,568.12 | 9.3K |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cerulean Pharma Inc. (DARE) Snapshot price: $0.3497
VP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
MOMENTA PHARMACEUTICALS INC No price found
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -28.80K |
—
|
—
|
0
|
Oct 1
| |||
Form 4
| +4.92% | 1.35K |
$33.95 | -$36,903.65 | 28.8K |
Scheduled
|
Jul 17 - Jul 20
| ||
Form 4
| +42.53% | 8.19K |
$35.10 | -$239,066.10 | 27.45K |
Scheduled
|
Jun 29 - Jun 30
| ||
Form 4
| +74.86% | 8.24K |
$30.15 | -$203,693.40 | 19.26K |
Scheduled
|
Jun 11 - Jun 12
| ||
Form 4
| +13.55% | 1.31K |
$28.97 | -$32,562.28 | 11.01K |
Scheduled
|
Apr 17 - Apr 20
| ||
Form 4
|
∞
| 9.7K |
$29.00 | -$153,758.00 | 9.7K |
Scheduled
|
Mar 5 - Mar 6
| ||
Form 4
| -100.00% | -6.89K |
$31.54 | -$217,373.68 |
0
|
Scheduled
|
Feb 14
| ||
Form 4
|
∞
| 6.89K |
$30.03 | -$93,333.24 | 6.89K |
Scheduled
|
Feb 12 - Feb 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| -100.00% | -1.58K |
$28.98 | -$45,701.46 |
0
|
Scheduled
|
Jan 22
| ||
Form 4
|
∞
| 1.58K |
$30.08 | -$25,868.80 | 1.58K |
Scheduled
|
Jan 17 - Jan 21
| ||
Form 4
| -100.00% | -6.81K |
$14.40 | -$98,121.60 |
0
|
Scheduled
|
Oct 21
| ||
Form 4
|
∞
| 6.81K |
$13.83 | -$40,604.88 | 6.81K |
Scheduled
|
Oct 17 - Oct 18
| ||
Form 4/A
| -31.27% | -4.72K |
—
|
—
| 10.38K |
Apr 13
| |||
Form 4
| -100.00% | -10.38K |
$14.77 | -$153,371.68 |
0
|
Scheduled
|
Apr 29
| ||
Form 4
| -31.27% | -4.72K |
—
|
—
| 10.38K |
Apr 13
| |||
Form 4
| -4.45% | -703.00 |
$13.10 | -$9,209.30 | 15.11K |
Scheduled
|
Feb 14
| ||
Form 4
| +80.72% | 7.06K |
$12.70 | -$37,312.60 | 15.81K |
Scheduled
|
Feb 12 - Feb 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |